𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety and efficacy of Rituximab in refractory pediatric systemic lupus erythematosus nephritis: a single-center experience of Northern Greece

✍ Scribed by Maria Trachana, Artemis Koutsonikoli, Evagelia Farmaki…

Book ID
120779990
Publisher
Springer
Year
2011
Tongue
English
Weight
258 KB
Volume
33
Category
Article
ISSN
0172-8172

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of rituximab in mode
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
✍ Joan T. Merrill; C. Michael Neuwelt; Daniel J. Wallace; Joseph C. Shanahan; Kevi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views

## Abstract ## Objective B cells are likely to contribute to the pathogenesis of systemic lupus erythematosus (SLE), and rituximab induces depletion of B cells. The Exploratory Phase II/III SLE Evaluation of Rituximab (EXPLORER) trial tested the efficacy and safety of rituximab versus placebo in p

Efficacy and safety of tacrolimus in ref
Efficacy and safety of tacrolimus in refractory ulcerative colitis and Crohn's disease: A single-center experience
✍ Aaron Benson; Terrence Barrett; Marshall Sparberg; Alan L. Buchman 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 2 views

## Background: The published experience regarding the use of tacrolimus in crohn's disease (cd) and ulcerative colitis (uc) refractory to more commonly used medical therapy has been fairly limited. our objective was to describe our experience with its use in a cohort of patients which, to our knowl